Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Phase I study of amonafide dosing based on acetylator phenotype.

Ratain MJ, Mick R, Berezin F, Janisch L, Schilsky RL, Vogelzang NJ, Lane LB. Phase I study of amonafide dosing based on acetylator phenotype. Cancer Res. 1993 May 15; 53(10 Suppl):2304-8.

View in: PubMed

collapse authors with profiles